Get the Stockscreener App
17.64
0.28%
0.03
After Hours:
18.17
0.53
+3.00%
Outset Medical Inc stock is traded at $17.64, with a volume of 171.75K.
It is up +0.28% in the last 24 hours and up +65.98% over the past month.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$17.61
Open:
$17.71
24h Volume:
171.75K
Relative Volume:
1.07
Market Cap:
$312.58M
Revenue:
$114.73M
Net Income/Loss:
$-140.94M
P/E Ratio:
-6.3913
EPS:
-2.76
Net Cash Flow:
$-126.18M
1W Performance:
-1.62%
1M Performance:
+65.98%
6M Performance:
+31.37%
1Y Performance:
-66.74%
1-Day Range:
$16.73
$17.99
1-Week Range:
$16.73
$19.90
52-Week Range:
$5.85
$72.60
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
17.64 | 327.33M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
133.57 | 228.79B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.21 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.48 | 144.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.96 | 103.72B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.16 | 43.87B | 5.54B | 4.18B | 623.10M | 7.00 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Outset Medical Inc (OM) Stock Price Down 8.67% on May 29 - GuruFocus
Smart Dialysis System Market Growth Potential is Booming Now: Outset Medical, Mesa Virginia Tech - openPR.com
Outset Medical (NASDAQ:OM) Receives “Sector Perform” Rating from Royal Bank of Canada - Defense World
Outset Medical (NASDAQ:OM) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says - Defense World
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation By Investing.com - Investing.com Nigeria
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation - Investing.com Australia
Outset Medical shares rise on RBC price target boost By Investing.com - Investing.com South Africa
OM: Analyst Shagun Singh Raises Price Target for Outset Medical - GuruFocus
Outset Medical shares rise on RBC price target boost - Investing.com
Outset Medical Inc. (OM) PT Raised to $21 at RBC Capital - StreetInsider
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating - marketscreener.com
Outset Medical Inc (OM) Shares Gap Down to $18.845 on May 20 - GuruFocus
RBC Capital Raises Price Target for Outset Medical (OM) to $21 | OM Stock News - GuruFocus
Outset Medical Inc (OM) Shares Down 2.3% on May 16 - GuruFocus
Outset Medical appoints Kevin O’Boyle to its Board - Medical Buyer
Outset Medical adds healthcare veteran to board By Investing.com - Investing.com Nigeria
Outset Medical appoints Kevin O’Boyle to board of directors - TipRanks
Outset Medical (OM) Welcomes Kevin O'Boyle to Board, Dale E. Jon - GuruFocus
Outset Medical (OM) Welcomes Kevin O'Boyle to Board, Dale E. Jones Steps Down | OM Stock News - GuruFocus
Outset Medical Appoints Kevin O’Boyle to Board - TipRanks
Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors - The Manila Times
Outset Medical adds healthcare veteran to board - Investing.com
Outset Medical (OM) Appoints Kevin O’Boyle to its Board - StreetInsider
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors - GlobeNewswire
Former NuVasive CFO Kevin O'Boyle Joins Outset Medical Board, Bringing 20-Year Medical Device Expertise - Stock Titan
Does Outset Medical (NASDAQ:OM) Have A Healthy Balance Sheet? - simplywall.st
Outset Medical First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Outset Medical to Present at RBC Global Healthcare Conference - GlobeNewswire
Outset Medical (NASDAQ:OM) Trading 35.3% Higher Following Analyst Upgrade - Defense World
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Outset Medical, Inc. Investors to Inquire About Securities Class Action InvestigationOM - GuruFocus
Outset Medical to Present at RBC Global Healthcare Conference | OM Stock News - GuruFocus
Outset Medical To Present At RBC Global Healthcare Conference - Barchart.com
Outset Medical, Inc. Class Action: Levi & Korsinsky Reminds Outset Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM - ACCESS Newswire
Outset Medical, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Investors who lost money on Outset Medical, Inc.(OM) should contact Levi & Korsinsky about pending Class ActionOM - ACCESS Newswire
Outset Medical, Inc. (NASDAQ:OM) Q1 2025 Earnings Call Transcript - Insider Monkey
Levi & Korsinsky Reminds Outset Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM - ACCESS Newswire
Outset Medical’s Positive Earnings Call Highlights Growth - TipRanks
Investors who Lost Money on Outset Medical, Inc. (OM) Should Contact Levi & Korsinsky About Pending Class ActionOM - ACCESS Newswire
Outset Medical (OM) Receives Target Price Increase from RBC Capital | OM Stock News - GuruFocus
Outset Medical stock holds as Oppenheimer maintains Perform rating By Investing.com - Investing.com Nigeria
Outset Medical (OM) Sees Price Target Increase Amid Growth | OM Stock News - GuruFocus
RBC Raises Price Target on Outset Medical to $14 From $12, Keeps Sector Perform Rating - marketscreener.com
Outset Medical stock holds as Oppenheimer maintains Perform rating - Investing.com
Oppenheimer Reiterates Perform Rating on Outset Medical Inc. (OM) - StreetInsider
Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Sales Transformation - GuruFocus
Outset Medical Reports Strong Q1 Growth and Improved Margins - TipRanks
Earnings call transcript: Outset Medical Q1 2025 reveals wider EPS loss - Investing.com
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Outset Medical Inc. (OM) Misses Q1 EPS by 294c - StreetInsider
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Outset Medical Inc Stock (OM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nash Marc | SVP Operations and R&D |
May 15 '25 |
Sale |
17.82 |
252 |
4,491 |
13,465 |
| Brottem John L. | General Counsel |
May 15 '25 |
Sale |
17.82 |
396 |
7,057 |
11,273 |
| Ahmed Nabeel | Chief Financial Officer |
May 15 '25 |
Sale |
17.81 |
584 |
10,401 |
16,096 |
0.31%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):